QA: GELESIS HOLDINGS INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001805087_2023_GELESIS_HOLDINGS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001805087, GELESIS HOLDINGS INC.

  xvar xval
0 AssetsCurrent 23,496,000
1 IntangibleAssetsNetIncludingGoodwill 13,413,000
2 PropertyPlantAndEquipmentNet 59,335,000
3 remainder_Assets 7,080,000
4 LiabilitiesCurrent 78,346,000
5 LiabilitiesNoncurrent 1,865,000
6 remainder_Liabilities 35,579,000
7 CostOfGoodsAndServicesSold 27,558,000
8 SellingGeneralAndAdministrativeExpense 99,135,000
9 ResearchAndDevelopmentExpense 18,613,000
10 remainder_Expenses -3,346,000
11 remainder_Revenues 25,767,000
12 remainder_NetIncome 60,413,000
13 remainder_ComprehensiveNetIncome -115,000
  yvar yval
0 Assets 103,324,000
1 Liabilities 115,790,000
2 Expenses 141,960,000
3 Revenues 25,767,000
4 StockholdersEquity -12,466,000
5 NetIncome -55,780,000
6 ComprehensiveNetIncome -55,837,500
7 BaseVar 223,684,500
8 EconomicCapitalRatio -0.705

Edgar->Model Mapping

Feature Distribution

Change over Time